13F-HR filed by HealthCor Management, L.P.
HealthCor Management, L.P. filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-15, with 58 holding rows worth $995,103,000.
- Accession
- 0001343781-22-000004
- Filer
- CIK 1343781
- Filed
- 2022-08-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2022
A holdings report, 58 entries on the cover page, a total value of $995,103,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $995,101,000 with VALUE read as thousands by filing date, 13F file number 028-11790. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BIOGEN INC COM | 09062X103 | Stock | 413,640 | $84,358,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 903,850 | $72,091,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 1,807,990 | $67,384,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 740,948 | $61,402,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 540,860 | $45,762,000 | thousands by filing date | |
| UnitedHealth Group Inc | 91324P102 | COM | 68,230 | $35,045,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 898,420 | $31,840,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 412,420 | $31,756,000 | thousands by filing date | |
| LIVANOVA PLC | G5509L101 | SHS | 486,550 | $30,395,000 | thousands by filing date | |
| HOLOGIC INC | 436440101 | COM | 402,110 | $27,866,000 | thousands by filing date | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 518,990 | $27,278,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 1,097,370 | $27,193,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 54,230 | $26,170,000 | thousands by filing date | |
| Cigna Corporation | 125523100 | COM | 96,470 | $25,422,000 | thousands by filing date | |
| Danaher Corporation | 235851102 | COM | 96,880 | $24,561,000 | thousands by filing date | |
| Eli Lilly and Company | 532457108 | COM | 70,630 | $22,900,000 | thousands by filing date | |
| CENCORA INC COM | 03073E105 | Stock | 156,910 | $22,200,000 | thousands by filing date | |
| HUMANA INC COM | 444859102 | Stock | 47,220 | $22,102,000 | thousands by filing date | |
| Abbott Laboratories | 002824100 | COM | 199,300 | $21,654,000 | thousands by filing date | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 1,418,088 | $19,598,000 | thousands by filing date | |
| SCHEIN HENRY INC | 806407102 | COM | 248,920 | $19,102,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 485,600 | $19,079,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 500,000 | $18,635,000 | thousands by filing date | call |
| SEAGEN INC | 81181C104 | COM | 103,060 | $18,235,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 234,130 | $17,787,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 923,400 | $17,766,000 | thousands by filing date | |
| AGILENT TECHNOLOGIES INC COM | 00846U101 | Stock | 138,280 | $16,424,000 | thousands by filing date | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 72,490 | $14,549,000 | thousands by filing date | |
| BECTON DICKINSON & CO | 075887109 | COM | 55,710 | $13,734,000 | thousands by filing date | |
| UNIVERSAL HLTH SVCS INC CL B | 913903100 | Stock | 134,040 | $13,499,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 35,040 | $11,430,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 1,209,880 | $10,006,000 | thousands by filing date | |
| THE COOPER COMPANIES | 216648402 | COM NEW | 30,770 | $9,635,000 | thousands by filing date | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 72,020 | $7,566,000 | thousands by filing date | |
| ISHARES TR | 464287556 | ISHARES BIOTECH | 53,940 | $6,345,000 | thousands by filing date | |
| HYPERFINE INC | 44916K106 | Common Stock | 2,749,400 | $6,131,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 74,780 | $5,573,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 1,721,925 | $4,770,000 | thousands by filing date | |
| Health Care Select Sector SPDR Fund | 81369Y209 | SHS | 34,610 | $4,438,000 | thousands by filing date | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 217,165 | $3,963,000 | thousands by filing date | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 499,640 | $3,757,000 | thousands by filing date | |
| QUANTERIX CORP | 74766Q101 | COMMON STOCK | 201,560 | $3,263,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 55,280 | $3,085,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 119,200 | $2,699,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 239,820 | $2,537,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 100,000 | $2,478,000 | thousands by filing date | call |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 10,000 | $2,367,000 | thousands by filing date | call |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 500,000 | $2,250,000 | thousands by filing date | |
| INSULET CORP COM | 45784P101 | Stock | 7,150 | $1,558,000 | thousands by filing date | |
| GERON CORP | 374163103 | COM | 1,000,000 | $1,550,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 27,070 | $1,545,000 | thousands by filing date | |
| LEAP THERAPEUTICS INC | 52187K101 | COM | 1,066,689 | $1,227,000 | thousands by filing date | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 220,082 | $975,000 | thousands by filing date | |
| EQRX INC | 26886C115 | *W EXP 12/17/202 | 99,998 | $81,000 | thousands by filing date | |
| LONGVIEW ACQUISITION CORP II | 54319Q113 | *W EXP 99/99/999 | 427,178 | $56,000 | thousands by filing date | |
| MEDICUS SCIENCES ACQUISITION | G5960S124 | *W EXP 02/12/202 | 82,663 | $15,000 | thousands by filing date | |
| ORION ACQUISITION CORP | 68626A116 | WTS | 137,305 | $12,000 | thousands by filing date | |
| EUCRATES BIOMEDICAL ACQU COR | G3141W122 | *W EXP 10/23/202 | 78,059 | $2,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001343781-22-000004 | this filing | 2022-08-15 | acceptance time not in the bulk data set |